These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34246283)

  • 21. Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease.
    Seo HJ; Park JE; Choi SM; Kim T; Cho SH; Lee KH; Song WK; Song J; Jeong HS; Kim DH; Kim BC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Consequences of Synapse Remodeling Following Astrocyte-Specific Regulation of Ephrin-B1 in the Adult Hippocampus.
    Koeppen J; Nguyen AQ; Nikolakopoulou AM; Garcia M; Hanna S; Woodruff S; Figueroa Z; Obenaus A; Ethell IM
    J Neurosci; 2018 Jun; 38(25):5710-5726. PubMed ID: 29793972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
    Beggiato S; Cassano T; Ferraro L; Tomasini MC
    Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome.
    Morice E; Farley S; Poirier R; Dallerac G; Chagneau C; Pannetier S; Hanauer A; Davis S; Vaillend C; Laroche S
    Neurobiol Dis; 2013 Oct; 58():156-68. PubMed ID: 23742761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
    Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
    Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease.
    Ceyzériat K; Ben Haim L; Denizot A; Pommier D; Matos M; Guillemaud O; Palomares MA; Abjean L; Petit F; Gipchtein P; Gaillard MC; Guillermier M; Bernier S; Gaudin M; Aurégan G; Joséphine C; Déchamps N; Veran J; Langlais V; Cambon K; Bemelmans AP; Baijer J; Bonvento G; Dhenain M; Deleuze JF; Oliet SHR; Brouillet E; Hantraye P; Carrillo-de Sauvage MA; Olaso R; Panatier A; Escartin C
    Acta Neuropathol Commun; 2018 Oct; 6(1):104. PubMed ID: 30322407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished activation of excitatory neurons in the prelimbic cortex leads to impaired working memory capacity in mice.
    Jiang LX; Huang GD; Tian YL; Cong RX; Meng X; Wang HL; Zhang C; Yu X
    BMC Biol; 2023 Aug; 21(1):171. PubMed ID: 37568146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shenqi Yizhi Granule attenuates Aβ
    Li P; Wu Q; Li X; Hu B; Wen W; Xu S
    Exp Gerontol; 2021 Aug; 151():111400. PubMed ID: 33974937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clusterin contributes to early stage of Alzheimer's disease pathogenesis.
    Oh SB; Kim MS; Park S; Son H; Kim SY; Kim MS; Jo DG; Tak E; Lee JY
    Brain Pathol; 2019 Mar; 29(2):217-231. PubMed ID: 30295351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial transcriptomics shows moxibustion promotes hippocampus astrocyte and neuron interaction.
    Zhang N; Shen Y; Zhu W; Li C; Liu S; Li H; Wang Y; Wang J; Zhang Q; Sun J; Xie L; Yu S; Wu Q
    Life Sci; 2022 Dec; 310():121052. PubMed ID: 36220370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease.
    Katsouri L; Birch AM; Renziehausen AWJ; Zach C; Aman Y; Steeds H; Bonsu A; Palmer EOC; Mirzaei N; Ries M; Sastre M
    Glia; 2020 May; 68(5):1017-1030. PubMed ID: 31799735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages.
    Devi L; Ohno M
    Pharmacol Biochem Behav; 2016 May; 144():60-6. PubMed ID: 26948858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.
    O'Leary TP; Stover KR; Mantolino HM; Darvesh S; Brown RE
    Behav Brain Res; 2020 Sep; 393():112731. PubMed ID: 32522622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.